| Year |
Citation |
Score |
| 1998 |
Rinne UK, Bracco F, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, Marsden CD. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group. Drugs. 55: 23-30. PMID 9483167 DOI: 10.2165/00003495-199855001-00004 |
0.56 |
|
| 1997 |
Rinne UK, Bracco F, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, Marsden CD, Dubini A, Orlando N, Grimaldi R. Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. Neurology. 48: 363-8. PMID 9040722 DOI: 10.1212/Wnl.48.2.363 |
0.549 |
|
| 1996 |
Smith L, De Salvia M, Jenner P, Marsden CD. An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 125-35. PMID 8684381 DOI: 10.1002/Mds.870110203 |
0.321 |
|
| 1995 |
Gnanalingham KK, Jenner P, Hunter AJ, Marsden CD. The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease. Psychopharmacology. 117: 287-297. PMID 7770604 DOI: 10.1007/Bf02246103 |
0.316 |
|
| 1992 |
Burn DJ, Mark MH, Playford ED, Maraganore DM, Zimmerman TR, Duvoisin RC, Harding AE, Marsden CD, Brooks DJ. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 42: 1894-900. PMID 1407569 DOI: 10.1212/Wnl.42.10.1894 |
0.483 |
|
| 1992 |
Lange KW, Löschmann PA, Wachtel H, Horowski R, Jähnig P, Jenner P, Marsden CD. Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. European Journal of Pharmacology. 212: 247-52. PMID 1350996 DOI: 10.1016/0014-2999(92)90337-4 |
0.3 |
|
| 1990 |
Rose S, Nomoto M, Jenner P, Marsden CD. Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets. Biochemical Pharmacology. 38: 3677-81. PMID 2597167 DOI: 10.1016/0006-2952(89)90572-8 |
0.407 |
|
| 1989 |
Temlett JA, Chong PN, Oertel WH, Jenner P, Marsden CD. The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset. European Journal of Pharmacology. 156: 197-206. PMID 2977118 DOI: 10.1016/0014-2999(88)90322-6 |
0.365 |
|
| 1989 |
Temlett JA, Quinn NP, Jenner PG, Marsden CD, Pourcher E, Bonnet AM, Agid Y, Markstein R, Lataste X. Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 261-5. PMID 2571082 DOI: 10.1002/mds.870040307 |
0.302 |
|
| 1989 |
Rose S, Nomoto M, Kelly E, Kilpatrick G, Jenner P, Marsden CD. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP. Neuroscience Letters. 101: 305-310. PMID 2505199 DOI: 10.1016/0304-3940(89)90550-8 |
0.392 |
|
| 1988 |
Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Advances in Neurology. 50: 377-84. PMID 3041760 |
0.483 |
|
| 1987 |
De Ceballos ML, Boyce S, Jenner P, Marsden CD. Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats. European Journal of Pharmacology. 130: 305-9. PMID 3792452 DOI: 10.1016/0014-2999(86)90282-7 |
0.387 |
|
| 1987 |
Dewar D, Jenner P, Marsden CD. Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus. Biochemical Pharmacology. 36: 1738-1741. PMID 3297065 DOI: 10.1016/0006-2952(87)90062-1 |
0.307 |
|
| 1987 |
Kelly E, Jenner P, Marsden CD. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats. The Journal of Pharmacy and Pharmacology. 39: 196-202. PMID 2883284 DOI: 10.1111/J.2042-7158.1987.Tb06248.X |
0.415 |
|
| 1986 |
Simpson MDC, Jenner P, Marsden CD. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat Biochemical Pharmacology. 35: 3501-3506. PMID 3768037 DOI: 10.1016/0006-2952(86)90618-0 |
0.366 |
|
| 1986 |
Simpson MDC, Jenner P, Marsden CD. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat Biochemical Pharmacology. 35: 3203-3208. PMID 3768017 DOI: 10.1016/0006-2952(86)90414-4 |
0.352 |
|
| 1986 |
Jenner P, Marsden CD. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Journal of Neural Transmission. Supplementum. 20: 11-39. PMID 3091760 |
0.327 |
|
| 1986 |
Nomoto M, Jenner P, Marsden CD. Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmoset. European Journal of Pharmacology. 121: 123-8. PMID 3082655 DOI: 10.1016/0014-2999(86)90401-2 |
0.376 |
|
| 1986 |
Quinn N, Critchley P, Parkes D, Marsden CD. When should levodopa be started? Lancet (London, England). 2: 985-6. PMID 2877169 DOI: 10.1016/S0140-6736(86)90642-2 |
0.337 |
|
| 1985 |
Rupniak NM, Hall MD, Mann S, Fleminger S, Kilpatrick G, Jenner P, Marsden CD. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat. Biochemical Pharmacology. 34: 2755-63. PMID 4040370 DOI: 10.1016/0006-2952(85)90577-5 |
0.395 |
|
| 1985 |
Kelly E, Jenner P, Marsden CD. The effects of dopamine and dopamine agonists on the release of 3H-GABA and 3H-5HT from rat nigral slices. Biochemical Pharmacology. 34: 2655-62. PMID 3925957 DOI: 10.1016/0006-2952(85)90563-5 |
0.345 |
|
| 1984 |
Boyce S, Kelly E, Reavill C, Jenner P, Marsden CD. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones. Biochemical Pharmacology. 33: 1747-52. PMID 6610420 DOI: 10.1016/0006-2952(84)90344-7 |
0.41 |
|
| 1984 |
Rupniak NMJ, Jenner P, Marsden CD. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment Neuroscience Letters. 50: 63-65. PMID 6541767 DOI: 10.1016/0304-3940(84)90463-4 |
0.37 |
|
| 1984 |
Jenner P, Rupniak NM, Rose S, Kelly E, Kilpatrick G, Lees A, Marsden CD. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neuroscience Letters. 50: 85-90. PMID 6436758 DOI: 10.1016/0304-3940(84)90467-1 |
0.411 |
|
| 1984 |
Kerwin R, Rupniak NMJ, Jenner P, Marsden CD. Functional increase in striatal dopaminergic activity following continuous long-term treatment with trifluoperazine Neuroscience Letters. 45: 329-334. PMID 6145129 DOI: 10.1016/0304-3940(84)90247-7 |
0.334 |
|
| 1984 |
Kilpatrick GJ, Jenner P, Marsden CD. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes European Journal of Pharmacology. 107: 71-78. PMID 6084599 DOI: 10.1016/0014-2999(84)90093-1 |
0.36 |
|
| 1983 |
Murugaiah K, Fleminger S, Theodorou A, Jenner P, Marsden CD. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake Biochemical Pharmacology. 32: 2495-2499. PMID 6684429 DOI: 10.1016/0006-2952(83)90008-4 |
0.367 |
|
| 1983 |
Reavill C, Jenner P, Marsden CD. Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways. Biochemical Pharmacology. 32: 865-870. PMID 6301501 DOI: 10.1016/0006-2952(83)90589-0 |
0.388 |
|
| 1983 |
Hall MD, Jenner P, Marsden CD. Differential labelling of dopamine receptors in rat brain in vivo: comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine. European Journal of Pharmacology. 87: 85-94. PMID 6188621 DOI: 10.1016/0014-2999(83)90053-5 |
0.367 |
|
| 1982 |
Taylor RJ, Reavill C, Jenner P, Marsden CD. Circling behavior following unilateral kainic acid injections into rat striatum. European Journal of Pharmacology. 76: 211-22. PMID 7333356 DOI: 10.1016/0014-2999(81)90503-3 |
0.315 |
|
| 1982 |
Jenner P, Hall MD, Murugaiah K, Rupniak N, Theodorou A, Marsden CD. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity Biochemical Pharmacology. 31: 325-328. PMID 7200363 DOI: 10.1016/0006-2952(82)90178-2 |
0.408 |
|
| 1982 |
Jenner P, Rupniak NM, Hall MD, Dyer R, Leigh N, Marsden CD. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment. European Journal of Pharmacology. 76: 31-6. PMID 6119220 DOI: 10.1016/0014-2999(81)90006-6 |
0.397 |
|
| 1981 |
Barbeau A, Duvoisin RC, Gerstenbrand F, Lakke JP, Marsden CD, Stern G. Classification of extrapyramidal disorders. Proposal for an international classification and glossary of terms. Journal of the Neurological Sciences. 51: 311-27. PMID 7276982 DOI: 10.1016/0022-510X(81)90109-X |
0.412 |
|
| 1980 |
Marsden CD, Duvoisin R. Scoliosis and Parkinson's Disease Jama Neurology. 37: 253-254. PMID 7362496 DOI: 10.1001/Archneur.1980.00500530091025 |
0.532 |
|
| 1978 |
Bédard P, Parkes JD, Marsden CD. Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. British Medical Journal. 1: 954-6. PMID 638546 DOI: 10.1136/bmj.1.6118.954 |
0.308 |
|
| 1978 |
Pycock CJ, Marsden CD. The rotating rodent: a two component system? European Journal of Pharmacology. 47: 167-75. PMID 340238 DOI: 10.1016/0014-2999(78)90388-6 |
0.414 |
|
| 1978 |
Jenner P, Pycock C, Marsden CD. The effect of chronic administration and withdrawal of amphetamine on cerebral dopamine receptor sensitivity. Psychopharmacology. 58: 131-6. PMID 98779 DOI: 10.1007/Bf00426895 |
0.303 |
|
| 1978 |
Dolphin A, Jenner P, Marsden CD. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat. The Journal of Pharmacy and Pharmacology. 30: 580-2. PMID 29100 DOI: 10.1111/J.2042-7158.1978.Tb13329.X |
0.405 |
|
| 1977 |
Sawaya MC, Dolphin A, Jenner P, Marsden CD, Meldrum BS. Noradrenaline-sensitive adenylate cyclase in slices of mouse limbic forebrain: characterisation and effect of dopaminergic agonists. Biochemical Pharmacology. 26: 1877-84. PMID 911341 DOI: 10.1016/0006-2952(77)90161-7 |
0.499 |
|
| 1977 |
Dolphin A, Christina M, Sawaya MC, Jenner P, Marsden CD. Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation. Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 167-73. PMID 909612 DOI: 10.1007/Bf00498559 |
0.52 |
|
| 1977 |
Donaldson IM, Dolphin AC, Jenner P, Pycock C, Marsden CD. Rotational behaviour produced in rats by unilateral electrolytic lesions of the ascending noradrenergic bundles. Brain Research. 138: 487-509. PMID 597720 DOI: 10.1016/0006-8993(77)90685-0 |
0.495 |
|
| 1977 |
Dolphin AC, Jenner P, Marsden CD, Sawaya MC. Central dopaminergic and noradrenergic components of bromocryptine-induced locomotor activity in mice [proceedings]. British Journal of Pharmacology. 59: 467P. PMID 576587 |
0.417 |
|
| 1977 |
Pycock CJ, Jenner PG, Marsden CD. The interaction of clonidine with dopamine-dependent behaviour in rodents. Naunyn-Schmiedeberg's Archives of Pharmacology. 297: 133-41. PMID 558529 DOI: 10.1007/BF00499922 |
0.31 |
|
| 1977 |
Dolphin AC, Jenner P, Sawaya MC, Marsden CD, Testa B. The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents. The Journal of Pharmacy and Pharmacology. 29: 727-34. PMID 22618 DOI: 10.1111/J.2042-7158.1977.Tb11450.X |
0.501 |
|
| 1976 |
Dolphin A, Jenner P, Marsden CD. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase. European Journal of Pharmacology. 35: 135-44. PMID 1253815 DOI: 10.1016/0014-2999(76)90308-3 |
0.571 |
|
| 1976 |
Dolphin A, Jenner P, Marsden CD. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity. Pharmacology, Biochemistry, and Behavior. 5: 431-9. PMID 1005491 DOI: 10.1016/0091-3057(76)90107-6 |
0.496 |
|
| 1976 |
Donaldson IM, Dolphin A, Jenner P, Marsden CD, Pycock C. The involvement of noradrenaline in motor activity as shown by rotational behaviour after unilateral lesions of the locus coeruleus. Brain : a Journal of Neurology. 99: 427-46. PMID 1000281 DOI: 10.1093/Brain/99.3.427 |
0.491 |
|
| 1976 |
Costall B, Marsden CD, Naylor RJ, Pycock CJ. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Brain Research. 118: 87-113. PMID 990957 DOI: 10.1016/0006-8993(76)90843-X |
0.305 |
|
| 1976 |
Dolphin AC, Jenner P, Marsden CD. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice. Pharmacology, Biochemistry, and Behavior. 4: 661-70. PMID 981283 DOI: 10.1016/0091-3057(76)90217-3 |
0.511 |
|
| 1976 |
Donaldson I, Dolphin A, Jenner P, Marsden CD, Pycock C. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus. European Journal of Pharmacology. 39: 179-91. PMID 976315 DOI: 10.1016/0014-2999(76)90126-6 |
0.495 |
|
| 1976 |
Donaldson IM, Dolphin A, Jenner P, Marsden CD, Pycock C. Contraversive circling behaviour produced by unilateral electrolytic lesions of the ventral noradrenergic bundle mimicking the changes seen with unilateral electrolytic lesions of the locus coeruleus. The Journal of Pharmacy and Pharmacology. 28: 329-31. PMID 6733 DOI: 10.1111/J.2042-7158.1976.Tb04171.X |
0.411 |
|
| 1975 |
Dolphin A, Jenner P, Marsden CD. Interference by alphamethylparatyrosine with three procedures for assay of cerebral catecholamines. Journal of Neurochemistry. 25: 897-8. PMID 1206407 DOI: 10.1111/J.1471-4159.1975.Tb04425.X |
0.362 |
|
| 1975 |
Dolphin A, Jenner P, Marsden CD. Proceedings: Biochemical evidence for the involvement of noradrenaline in motor activity produced by L-DOPA in rodents. British Journal of Pharmacology. 55: 292P. PMID 1201420 |
0.446 |
|
| 1975 |
Duvoisin RC, Marsden CD. Note on the scoliosis of Parkinsonism Journal of Neurology, Neurosurgery and Psychiatry. 38: 787-793. PMID 1185199 DOI: 10.1136/jnnp.38.8.787 |
0.53 |
|
| 1975 |
Jenner P, Marsden CD. The influence of piribedil (ET495) on components of locomotor activity. European Journal of Pharmacology. 33: 211-215. PMID 1175688 DOI: 10.1016/0014-2999(75)90160-0 |
0.359 |
|
| 1975 |
Dolphin A, Jenner P, Marsden CD, Pycock C, Tarsy D. Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents. Psychopharmacologia. 41: 133-8. PMID 1171487 DOI: 10.1007/Bf00421070 |
0.542 |
|
| 1975 |
Dolphin A, Jenner P, Marsden CD. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia. British Journal of Pharmacology. 54: 246P-247P. PMID 1148534 |
0.471 |
|
| 1975 |
Duvoisin RC, Marsden CD. Alpha-methyldopamine as a dopaminergic agonist Advances in Neurology. 9: 243-248. PMID 1146655 |
0.468 |
|
| 1975 |
Marsden CD, Duvoisin RC, Jenner P, Parkes JD, Pycock C, Tarsy D. Relationship between animal models and clinical parkinsonism. Advances in Neurology. 9: 165-75. PMID 1146651 |
0.475 |
|
| 1974 |
Marsden CD, Dolphin A, Duvoisin RC, Jenner P, Tarsy D. Role of noradrenaline in levodopa reversal of reserpine akinesia. Brain Research. 77: 521-5. PMID 4854165 DOI: 10.1016/0006-8993(74)90643-X |
0.589 |
|
| 1974 |
Duvoisin RC, Marsden CD. Reversal of reserpine-induced bradykinesia by a-methyldopa - new light on its modus operandi Brain Research. 71: 178-182. PMID 4821419 DOI: 10.1016/0006-8993(74)90204-2 |
0.436 |
|
| Show low-probability matches. |